Skip to main content

The Role of Pharmacists in Optimising Drug Therapy

  • Chapter
  • First Online:
Optimizing Pharmacotherapy in Older Patients

Part of the book series: Practical Issues in Geriatrics ((PIG))

Abstract

In this chapter, we aim to present and discuss the activities performed by pharmacists at individual patient level for optimising drug therapy and the role of pharmacists in training other healthcare professionals (HCPs) towards medicines optimisation in older people. Then, we describe the different models of care and their levels of implementation in the ambulatory, acute and long-term care settings. The case of pharmacist prescribing is also addressed.

There has been a strong evolution over the last decades in the role played by pharmacists in optimising drug therapy for older people, either as individual HCPs or as part of multidisciplinary teams. This role now goes far beyond medication supply and checking drug interactions, for example. In parallel, educational programs to train pharmacists in patient-centred care and geriatric pharmacotherapy have been developed, and pharmacists are now better equipped to take on their expanding roles as part of multidisciplinary teams.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Griese-Mammen N, Hersberger KE, Messerli M, Leikola S, Horvat N, van Mil JWF, et al. PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 2018;40(5):1199–208.

    PubMed  Google Scholar 

  2. Blenkinsopp A, Bond C, Raynor DK. Medication reviews. Br J Clin Pharmacol. 2012;74(4):573–80.

    PubMed  PubMed Central  Google Scholar 

  3. O'Mahony D, Gudmundsson A, Soiza RL, Petrovic M, Jose Cruz-Jentoft A, Cherubini A, et al. Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial. Age Ageing. 2020;49(4):605–14.

    PubMed  Google Scholar 

  4. Chen TF. Pharmacist-led home medicines review and residential medication management review: the Australian model. Drugs Aging. 2016;33(3):199–204.

    PubMed  Google Scholar 

  5. Australian Pharmaceutical Advisory Council. National guidelines to achieve the continuum of quality use of medicines between hospital and community. Canberra: Commonwealth Department of Health and Family Services; 1998.

    Google Scholar 

  6. review I-IfHIMr. http://www.ihi.org:80/resources/Pages/Tools/MedicationReconciliationReview.aspx.

  7. Redmond P, Grimes TC, McDonnell R, Boland F, Hughes C, Fahey T. Impact of medication reconciliation for improving transitions of care. Cochrane Database Syst Rev. 2018;8:CD010791.

    PubMed  Google Scholar 

  8. Cameli D, Francis M, Francois VE, Medder NR, Von Eden L, Truglio-Londrigan M. A systematic review of medication reconciliation strategies to reduce medication errors in community dwelling older adults. JBI Libr Syst Rev. 2012;10(42 Suppl):1–18.

    PubMed  Google Scholar 

  9. Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6(2):e010003.

    PubMed  PubMed Central  Google Scholar 

  10. Najafzadeh M, Schnipper JL, Shrank WH, Kymes S, Brennan TA, Choudhry NK. Economic value of pharmacist-led medication reconciliation for reducing medication errors after hospital discharge. Am J Manag Care. 2016;22(10):654–61.

    PubMed  Google Scholar 

  11. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.

    PubMed  PubMed Central  Google Scholar 

  12. Kini V, Ho PM. Interventions to improve medication adherence: a review. JAMA. 2018;320(23):2461–73.

    PubMed  Google Scholar 

  13. Marcum ZA, Hanlon JT, Murray MD. Improving medication adherence and health outcomes in older adults: an evidence-based review of randomized controlled trials. Drugs Aging. 2017;34(3):191–201.

    PubMed  PubMed Central  Google Scholar 

  14. Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial. JAMA. 2018;320(18):1889–98.

    PubMed  PubMed Central  Google Scholar 

  15. Joseph-Williams N, Lloyd A, Edwards A, Stobbart L, Tomson D, Macphail S, et al. Implementing shared decision making in the NHS: lessons from the MAGIC programme. BMJ. 2017;357:j1744.

    PubMed  PubMed Central  Google Scholar 

  16. Jansen J, Naganathan V, Carter SM, McLachlan AJ, Nickel B, Irwig L, et al. Too much medicine in older people? Deprescribing through shared decision making. BMJ. 2016;353:i2893.

    PubMed  Google Scholar 

  17. Tinetti ME, Naik AD, Dindo L, Costello DM, Esterson J, Geda M, et al. Association of patient priorities-aligned decision-making with patient outcomes and ambulatory health care burden among older adults with multiple chronic conditions: a nonrandomized clinical trial. JAMA Intern Med. 2019;179(12):1688–97.

    PubMed  PubMed Central  Google Scholar 

  18. Loganathan M, Singh S, Franklin BD, Bottle A, Majeed A. Interventions to optimise prescribing in care homes: systematic review. Age Ageing. 2011;40(2):150–62.

    PubMed  Google Scholar 

  19. Alldred DP, Kennedy MC, Hughes C, Chen TF, Miller P. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2016;2:CD009095.

    PubMed  Google Scholar 

  20. Duckett A, Cuoco T, Pride P, Wiley K, Iverson PJ, Marsden J, et al. Academic detailing to teach aging and geriatrics. Gerontol Geriatr Educ. 2015;36(4):331–42.

    PubMed  Google Scholar 

  21. Lutters M, Harbarth S, Janssens JP, Freudiger H, Herrmann F, Michel JP, et al. Effect of a comprehensive, multidisciplinary, educational program on the use of antibiotics in a geriatric university hospital. J Am Geriatr Soc. 2004;52(1):112–6.

    PubMed  Google Scholar 

  22. Nicolas C, Balardy L, Antoine V, Albarede J, Azria D, Cristol L, et al. Spreading geriatric oncology culture through professional caregivers: results of a French massive open online course (MOOC). J Geriatr Oncol. 2021;13(1):94–9.

    PubMed  Google Scholar 

  23. O'Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2007;4:CD000409.

    Google Scholar 

  24. Cullinan S, O'Mahony D, Byrne S. Use of an e-learning educational module to better equip doctors to prescribe for older patients: a randomised controlled trial. Drugs Aging. 2017;34(5):367–74.

    PubMed  Google Scholar 

  25. Rankin A, Cadogan CA, Patterson SM, Kerse N, Cardwell CR, Bradley MC, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;9:CD008165.

    PubMed  Google Scholar 

  26. Elliott RA. Geriatric medicine and pharmacy practice: a historical perspective. J Pharm Pract Res. 2016;46:9.

    Google Scholar 

  27. Lee JK, Slack MK, Martin J, Ehrman C, Chisholm-Burns M. Geriatric patient care by U.S. pharmacists in healthcare teams: systematic review and meta-analyses. J Am Geriatr Soc. 2013;61(7):1119–27.

    PubMed  Google Scholar 

  28. Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29(6):495–510.

    PubMed  Google Scholar 

  29. Imfeld-Isenegger TL, Soares IB, Makovec UN, Horvat N, Kos M, van Mil F, et al. Community pharmacist-led medication review procedures across Europe: characterization, implementation and remuneration. Res Soc Adm Pharm. 2020;16(8):1057–66.

    Google Scholar 

  30. Soares IB, Imfeld-Isenegger TL, Makovec UN, Horvat N, Kos M, Arnet I, et al. A survey to assess the availability, implementation rate and remuneration of pharmacist-led cognitive services throughout Europe. Res Soc Adm Pharm. 2020;16(1):41–7.

    Google Scholar 

  31. Latif A. Community pharmacy medicines use review: current challenges. Integr Pharm Res Pract. 2017;7:83–92.

    PubMed  Google Scholar 

  32. Alshehri AA, Cheema E, Yahyouche A, Haque MS, Jalal Z. Evaluating the role and integration of general practice pharmacists in England: a cross-sectional study. Int J Clin Pharm. 2021;43(6):1609–18.

    PubMed  PubMed Central  Google Scholar 

  33. Dautzenberg L, Bretagne L, Koek HL, Tsokani S, Zevgiti S, Rodondi N, et al. Medication review interventions to reduce hospital readmissions in older people. J Am Geriatr Soc. 2021;69(6):1646–58.

    PubMed  PubMed Central  Google Scholar 

  34. Delgado-Silveira E, Velez-Diaz-Pallares M, Munoz-Garcia M, Correa-Perez A, Alvarez-Diaz AM, Cruz-Jentoft AJ. Effects of hospital pharmacist interventions on health outcomes in older polymedicated inpatients: a scoping review. Eur Geriatr Med. 2021;12(3):509–44.

    CAS  PubMed  Google Scholar 

  35. Van der Linden L, Hias J, Walgraeve K, Flamaing J, Tournoy J, Spriet I. Clinical pharmacy services in older inpatients: an evidence-based review. Drugs Aging. 2020;37(3):161–74.

    PubMed  Google Scholar 

  36. European Association of Hospital Pharmacists aKU, Center for Medicines Optimisation. European Statements of Hospital Pharmacy survey results 2018: statements sections 1, 3, 4. Brussels: EAHP; 2018–2019.

    Google Scholar 

  37. Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017;6:37–46.

    PubMed  PubMed Central  Google Scholar 

  38. Spinewine A, Evrard P, Hughes C. Interventions to optimize medication use in nursing homes: a narrative review. Eur Geriatr Med. 2021;12(3):551–67.

    PubMed  PubMed Central  Google Scholar 

  39. Sluggett JK, Bell JS, Lang C, Corlis M, Whitehead C, Wesselingh SL, et al. Variation in provision of collaborative medication reviews on entry to long-term care facilities. J Am Med Dir Assoc. 2021;22(1):148–55 e1.

    PubMed  Google Scholar 

  40. Chen EYH, Wang KN, Sluggett JK, Ilomaki J, Hilmer SN, Corlis M, et al. Process, impact and outcomes of medication review in Australian residential aged care facilities: a systematic review. Australas J Ageing. 2019;38(Suppl 2):9–25.

    PubMed  Google Scholar 

  41. Strauven G, Anrys P, Vandael E, Henrard S, De Lepeleire J, Spinewine A, et al. Cluster-controlled trial of an intervention to improve prescribing in nursing homes study. J Am Med Dir Assoc. 2019;20(11):1404–11.

    PubMed  Google Scholar 

  42. Wouters H, Scheper J, Koning H, Brouwer C, Twisk JW, van der Meer H, et al. Discontinuing inappropriate medication use in nursing home residents: a cluster randomized controlled trial. Ann Intern Med. 2017;167(9):609–17.

    PubMed  Google Scholar 

  43. Cateau D, Ballabeni P, Niquille A. Effects of an interprofessional quality circle-deprescribing module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial. BMC Geriatr. 2021;21(1):289.

    PubMed  PubMed Central  Google Scholar 

  44. Bollen A, Harrison R, Aslani P, van Haastregt JCM. Factors influencing interprofessional collaboration between community pharmacists and general practitioners—a systematic review. Health Soc Care Community. 2019;27(4):e189–212.

    PubMed  Google Scholar 

  45. Rawlinson C, Carron T, Cohidon C, Arditi C, Hong QN, Pluye P, et al. An overview of reviews on interprofessional collaboration in primary care: barriers and facilitators. Int J Integr Care. 2021;21(2):32.

    PubMed  PubMed Central  Google Scholar 

  46. Sangaleti C, Schveitzer MC, Peduzzi M, Zoboli E, Soares CB. Experiences and shared meaning of teamwork and interprofessional collaboration among health care professionals in primary health care settings: a systematic review. JBI Database System Rev Implement Rep. 2017;15(11):2723–88.

    PubMed  Google Scholar 

  47. Weeks G, George J, Maclure K, Stewart D. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Database Syst Rev. 2016;11:CD011227.

    PubMed  Google Scholar 

  48. Berry D, Bradlow A, Courtenay M. Patients’ attitudes towards, and information needs in relation to, nurse prescribing in rheumatology. J Clin Nurs. 2008;17(2):266–73.

    PubMed  Google Scholar 

  49. Cooper R, Anderson C, Avery T, Bissell P, Guillaume L, Hutchinson A, et al. Stakeholders’ views of UK nurse and pharmacist supplementary prescribing. J Health Serv Res Policy. 2008;13(4):215–21.

    PubMed  Google Scholar 

  50. Emmerton L, Marriott J, Bessell T, Nissen L, Dean L. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci. 2005;8(2):217–25.

    PubMed  Google Scholar 

  51. Cooper RJ, Bissell P, Ward P, Murphy E, Anderson C, Avery T, et al. Further challenges to medical dominance? The case of nurse and pharmacist supplementary prescribing. Health (London). 2012;16(2):115–33.

    PubMed  Google Scholar 

  52. Iqbal MZ, Khan AH, Iqbal MS, Syed Sulaiman SA. A review of pharmacist-led interventions on diabetes outcomes: an observational analysis to explore diabetes care opportunities for pharmacists. J Pharm Bioallied Sci. 2019;11(4):299–309.

    PubMed  PubMed Central  Google Scholar 

  53. Kroezen M, Francke AL, Groenewegen PP, van Dijk L. Nurse prescribing of medicines in Western European and Anglo-Saxon countries: a survey on forces, conditions and jurisdictional control. Int J Nurs Stud. 2012;49(8):1002–12.

    PubMed  Google Scholar 

  54. Jebara T, Cunningham S, MacLure K, Awaisu A, Pallivalapila A, Stewart D. Stakeholders’ views and experiences of pharmacist prescribing: a systematic review. Br J Clin Pharmacol. 2018;84(9):1883–905.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen Byrne .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Spinewine, A., Byrne, S., Dalleur, O. (2023). The Role of Pharmacists in Optimising Drug Therapy. In: Cherubini, A., Mangoni, A.A., O’Mahony, D., Petrovic, M. (eds) Optimizing Pharmacotherapy in Older Patients. Practical Issues in Geriatrics. Springer, Cham. https://doi.org/10.1007/978-3-031-28061-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-28061-0_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-28060-3

  • Online ISBN: 978-3-031-28061-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics